Get the Stockscreener App
5.27
2.33%
0.12
After Hours:
4.80
-0.47
-8.92%
Precipio Inc stock is traded at $5.27, with a volume of 6,011.
It is up +2.33% in the last 24 hours and down -26.40% over the past month.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
See More
Previous Close:
$5.15
Open:
$5
24h Volume:
6,011
Relative Volume:
0.76
Market Cap:
$7.81M
Revenue:
$15.81M
Net Income/Loss:
$-4.90M
P/E Ratio:
-1.5409
EPS:
-3.42
Net Cash Flow:
$-2.65M
1W Performance:
-15.95%
1M Performance:
-26.40%
6M Performance:
-22.44%
1Y Performance:
-16.22%
1-Day Range:
$4.895
$5.43
1-Week Range:
$4.895
$6.0921
52-Week Range:
$4.31
$10.74
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
12325 EMMET ST, OMAHA, CT
Compare PRPO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
5.27 | 7.81M | 15.81M | -4.90M | -2.65M | -3.42 |
|
TMO
Thermo Fisher Scientific Inc
|
437.91 | 165.21B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
181.77 | 130.05B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
393.73 | 31.91B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
103.00 | 29.38B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
154.73 | 27.28B | 15.41B | 1.37B | 2.11B | 7.50 |
Precipio Inc Stock (PRPO) Latest News
Precipio COO Ahmed Zaki Sabet acquires shares worth $473 - Investing.com
Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth ... - Yahoo Finance
Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth Initiatives Unveiled - GuruFocus
Precipio, Inc. (NASDAQ:PRPO) Q4 2024 Earnings Call Transcript - Insider Monkey
Precipio Reports Positive Q4 Financial Results - TipRanks
Earnings call transcript: Precipio Q4 2024 sees revenue growth, strategic shifts - Investing.com India
Precipio Full Year 2024 Earnings: US$2.93 loss per share (vs US$4.51 loss in FY 2023) - Yahoo Finance
Precipio announces executive option grants tied to stock performance - MSN
Precipio Announces Q4 and year-end 2024 Shareholder Update Call - The Manila Times
Precipio, Inc. to Host Q4 and Year-End 2024 Corporate Update Call on March 31, 2025 - Nasdaq
Precipio to Reveal Full Year Performance: Key Updates Coming March 31 - StockTitan
(PRPO) Trading Advice - Stock Traders Daily
Precipio (NASDAQ:PRPO) Stock Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Precipio, Inc. to Host Earnings Call - ACCESS Newswire
Objective long/short (PRPO) Report - news.stocktradersdaily.com
Precipio (NASDAQ:PRPO) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
Precipio Re-Launches All CLIA Lab and Pharmacological Research Projects at its New Haven, CT Facility - ACCESS Newswire
Precipio, Inc. Announces Pricing Of $2,748,000 Registered Direct Offering - ACCESS Newswire
Precipio achieves positive adjusted EBITDA, cash flow in Q4 - Yahoo Finance
Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited) - TradingView
Precipio, Inc. Reports Positive Adjusted EBITDA and Cash Flow for Q4 2024 - Nasdaq
How Precipio Finally Turned the Corner: Inside the Q4 Financial Breakthrough - StockTitan
(PRPO) Trading Report - Stock Traders Daily
Investors Still Aren't Entirely Convinced By Precipio, Inc.'s (NASDAQ:PRPO) Revenues Despite 28% Price Jump - Simply Wall St
Precipio Announces Q3-2019 Corporate Update Call for Shareholders - ACCESS Newswire
PRPO stock touches 52-week high at $7.42 amid market optimism - MSN
Precipio (NASDAQ:PRPO) Stock Passes Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 - br.ADVFN.com
Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results - br.ADVFN.com
PRPOPrecipio Granted 180 Day NASDAQ Extension to Regain Compliance - br.ADVFN.com
(PRPO) Proactive Strategies - Stock Traders Daily
Precipio (NASDAQ:PRPO) Stock Passes Above 200 Day Moving Average – Here’s Why - Armenian Reporter
Precipio Grants Options to Officers as Part of Long-Term Incentive Equity Program - Defense World
Precipio announces executive option grants tied to stock performance By Investing.com - Investing.com UK
Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs - The Manila Times
Precipio Adopts Performance-Based Stock Options for 2025 - TipRanks
Precipio Management Bets Big: Opts for Stock Options That Only Vest at $30 Share Price - StockTitan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio - Yahoo Finance
Top Research Reports for Visa, AbbVie & Analog Devices - Yahoo Finance
Investors Aren't Entirely Convinced By Precipio, Inc.'s (NASDAQ:PRPO) Revenues - Simply Wall St
Long Term Trading Analysis for (PRPO) - Stock Traders Daily
Precipio (NASDAQ:PRPO) Stock Quotes, Forecast and News Summary - Benzinga
(PRPO) Trading Signals - Stock Traders Daily
PRPO (Precipio) 3-Year Book Growth Rate : -14.20% (As of Sep. 2024) - GuruFocus.com
How to Take Advantage of moves in (PRPO) - Stock Traders Daily
PRPO (Precipio) 3-Year EPS without NRI Growth Rate : 28.00% (As of Sep. 2024) - GuruFocus.com
PRPO (Precipio) 3-Year EBITDA Growth Rate : 32.10% (As of Sep. 2024) - GuruFocus.com
PRPO (Precipio) 3-Year Revenue Growth Rate : 16.60% (As of Sep. 2024) - GuruFocus.com
PRPO (Precipio) Future 3-5Y Total Revenue Growth Rate : N/A (As of Nov. 26, 2024) - GuruFocus.com
PRPO (Precipio) Growth Rank : 3 (As of Nov. 25, 2024) - GuruFocus.com
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Precipio Inc Stock (PRPO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SANDBERG RICHARD A | Director |
Dec 13 '24 |
Sale |
6.20 |
12,000 |
74,400 |
4,525 |
3.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):